Document is current
Any future updates will be listed below
-
Authors
Pezzoli, Gianni
Cereda, Emanuele https://orcid.org/0000-0002-0747-1951
Amami, Paolo
Colosimo, Santo
Barichella, Michela
Sacilotto, Giorgio
Zecchinelli, Anna
Zini, Michela
Ferri, Valentina
Bolliri, Carlotta
Calandrella, Daniela
Bonelli, Maria Grazia
Cereda, Viviana
Reali, Elisa
Caronni, Serena
Cassani, Erica
Canesi, Margherita
del Sorbo, Francesca
Soliveri, Paola
Zecca, Luigi
Klersy, Catherine
Cilia, Roberto
Isaias, Ioannis U.
- License Information
-
More Information
Article History
Received: 26 August 2022
Revised: 14 November 2022
Accepted: 17 November 2022
First Online: 27 November 2022
Declarations
:
: All authors have no conflict of interest to declare concerning the research related to this manuscript. GP, RC, SC, MZ, MGB, MC, FdS, PS, LZ, and EC: none. PA, MB, GS, VF, CB, DC, VC, ER, SC, EC, CK, and IUI: research grant from the Fondazione Grigioni per il Morbo di Parkinson. AZ: Advisory Board (Expert testimony) for Bial, Zambon, Italfarmaco. MC: Congress support by the International Parkinson and Movement Disorder Society (MDS) and Accademia per lo Studio della Malattia di Parkinson e i Disordini del Movimento (Accademia LIMPE-DISMOV). IUI: research grant by the German Research Foundation (DFG), the Marlene and Paolo Fresco Foundation, and Medtronic Inc. Honoraria from Medtronic Inc and Newronika Spa.
